Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory

BACKGROUND: Psoriasis symptoms have a significant negative impact on health-related quality of life, impairing physical functioning and well-being. OBJECTIVE: To evaluate the impact of brodalumab, a human anti-interleukin-17R monoclonal antibody, on psoriasis symptom severity as measured by a novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, KB, Kimball, AB, Chau, D, Viswanathan, HN, Li, J, Revicki, DA, Kricorian, G, Ortmeier, BG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153951/
https://www.ncbi.nlm.nih.gov/pubmed/24079852
http://dx.doi.org/10.1111/bjd.12636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153951/
https://www.ncbi.nlm.nih.gov/pubmed/24079852
http://dx.doi.org/10.1111/bjd.12636

Ejemplares similares